The Week in Cancer News: Colorectal Cancer in Adolescence
Colorectal cancer diagnoses in teens and young adults are often caught at advanced stages, and 1 in 8 cancers is linked to an infection, which is often preventable.
Progress Against Cancer
Colorectal cancer diagnoses in teens and young adults are often caught at advanced stages, and 1 in 8 cancers is linked to an infection, which is often preventable.
Identifying inherited gene variants can uncover hereditary cancer risk and guide treatment. Sometimes, when a patient is diagnosed with cancer, genetic testing is offered to identify whether the patient has inherited genetic alterations; these...
The fall issue of Cancer Today explores treatment advances for people with multiple myeloma whose cancer has returned or stopped responding to treatment, including CAR T-cell therapies and bispecific antibodies. The issue also covers...
Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use of HER2-targeted therapy for patients with metastatic or recurrent salivary gland cancer with HER2 overexpression.
Radiation delivered over several sessions reduced recurrence for large brain metastases, and an experimental SERD may delay progression in estrogen receptor-positive breast cancer.
The second installment of Cancer Research Catalyst’s new monthly series, “Unboxing Cancer News,” highlights exciting cancer research discoveries reported during September, including the effects of early-life sugar restriction on cancer risk, the potential of...
A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy. Personalized immunotherapies are an emerging treatment approach that directs the patient’s immune response to target their unique cancer. To design...
During the opening plenary session of the AACR Special Conference in Cancer Research: Bridging Discovery and Clinical Impact in Pediatric Cancer, the keynote presenter, Charles Mullighan, MBBS (Hons), MSc, MD, and the 2025 AACR-St....
Could higher rates of binge drinking be contributing to an increase in early-onset cancers? Mary Beth Terry, PhD, of Columbia University; Yin Cao, ScD, MPH, of Washington University School of Medicine in St. Louis;...
An FDA committee supports a liquid biopsy that screens for up to 50 cancers, and the FDA approves a drug combo for certain people with breast cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More